Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Exenatide maintained glycemic control with associated weight reduction over 2 years in patients with type 2 diabetes
North America dominates the market landscape, supported by favorable reimbursement policies, advanced healthcare infrastructure, and high treatment adoption rates
MeAgain transforms that effort into an engaging experience by incorporating an adorable capybara that motivates users to reach their protein, fiber, water, and exercise goals
The present study finds a significant acute effect of GLP-1-based therapies in increasing % FMD but in the long term this increase was not statistically significant
These agents mimic the action of endogenous GLP-1, an incretin hormone naturally secreted by intestinal L-cells in response to food intake
US$ 22.74
US$ 29.76
US$ 22.91
US$ 25.87
US$ 20.28
US$ 21.88
